Skip to main content

Advertisement

Log in

Flexibility of 3D Extruded Printing for a Novel Controlled-Release Puerarin Gastric Floating Tablet: Design of Internal Structure

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The objective of this study was to investigate the development of a novel puerarin gastric floating system with a concentric annular internal pattern by a 3D extrusion-based printing technique and to explore the flexibility of turning the release behavior through the design of the internal structure. The composition consisted of the conventional sustained-release pharmaceutical excipients without addition of foaming agent or light materials. First, the proper alcohol/water proportion was selected for the binding agent. The desired drug release behaviors and good floating properties were obtained either through modification of the formulation composition or adjustment of the internal structure. In vitro, the printed tablets were evaluated for drug release, mechanical properties, lag time, and floating duration time. The in vivo behaviors of the formulations were noted at certain time intervals through assessment of the radiographic pictures of healthy volunteers. The gastric retention time in the 3D-printed tablet was approximately 6 h in vivo. Results indicated these puerarin gastric floating 3D-printed tablets had great potential to achieve good gastric residence time and controlled release. Therefore, 3D extrusion-based printing appears to be appropriate for the production of oral administration systems, owing to its flexibility and the great floating ability and controlled-release capacity of its products.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Awasthi R, Kulkarni GT. Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: where do we stand? Drug Delivery. 2014;23(2):378–94.

    Article  PubMed  Google Scholar 

  2. Porwal A, Dwivedi H, Pathak K, Porwal A, Dwivedi H, Pathak K. Decades of research in drug targeting using gastroretentive drug delivery systems for antihypertensive therapy. Brazjpharmsci. 2017;53(3).

  3. Sathish D, ., Himabindu S, ., Y Shravan K, Y Madhusudan R. Floating drug delivery systems for prolonging gastric residence time: a review. Current Drug Delivery 2011;8(5):-, 494, 510.

  4. Yu DG, Zhu LM, Branford-White CJ, Yang XL. Three-dimensional printing in pharmaceutics: promises and problems. J Pharm Sci. 2008;97(9):3666–90.

    Article  CAS  PubMed  Google Scholar 

  5. D’Aveni R. The 3-D printing revolution. ICIS Chem Bus. 2015.

  6. Melocchi A, Parietti F, Loreti G, Maroni A, Gazzaniga A, Zema L. 3D printing by fused deposition modeling (FDM) of a swellable/erodible capsular device for oral pulsatile release of drugs. J Drug Deliv Sci Technol. 2015;30:360–7.

    Article  CAS  Google Scholar 

  7. Skowyra J, Pietrzak K, Alhnan MA. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. European Journal of Pharmaceutical Sciences Official Journal of the European Federation for Pharmaceutical Sciences. 2015;68:11–7.

    Article  CAS  PubMed  Google Scholar 

  8. Pietrzak K, Isreb A, Alhnan MA. A flexible-dose dispenser for immediate and extended release 3D printed tablets. Eur J Pharm Biopharm. 2015;96:380–7.

    Article  CAS  PubMed  Google Scholar 

  9. Alvaro G, Pamela RM, Asma B, Basit AW, Simon G. Effect of geometry on drug release from 3D printed tablets. Int J Pharm. 2015;494(2):657–63.

    Article  Google Scholar 

  10. Yu D, Branford-White C, Zh ZL, Li X, Yang X. Novel drug delivery devices for providing linear release profiles fabricated by 3DP. Int J Pharm. 2009;370(1):160–6.

    Article  CAS  PubMed  Google Scholar 

  11. Sadia M, Arafat B, Ahmed W, Forbes RE, Alhnan MA. Channelled tablets: an innovative approach to accelerating drug release from 3D printed tablets. J Control Release. 2017;269:1–32.

    Google Scholar 

  12. Li Q, Guan X, Cui M, Zhu Z, Chen K, Wen H, et al. Preparation and investigation of novel gastro-floating tablets with 3D extrusion-based printing. Int J Pharm. 2018;535(1–2):325–32.

    Article  CAS  PubMed  Google Scholar 

  13. Goyanes A, Buanz AB, Basit AW, Gaisford S. Fused-filament 3D printing (3DP) for fabrication of tablets. Int J Pharm. 2014;476(1–2):88–92.

    Article  CAS  PubMed  Google Scholar 

  14. On-demand manufacturing of immediate release levetiracetam tablets using pressure-assisted microsyringe printing. Eur J Pharm Biopharm. 2018;134:29–36.

    Google Scholar 

  15. Kyobula M, Adedeji A, Alexander MR, Saleh E, Wildman R, Ashcroft I, et al. 3D inkjet printing of tablets exploiting bespoke complex geometries for controlled and tuneable drug release. J Control Release. 2017;261:207–15.

    Article  CAS  PubMed  Google Scholar 

  16. Leong KF, Chua CK, Gui WS, Verani. Building porous biopolymeric microstructures for controlled drug delivery devices using selective laser sintering. Int J Adv Manuf Technol 2006;31(5–6):483–489.

  17. Martinez PR, Goyanes A, Basit AW, Gaisford S. Influence of geometry on the drug release profiles of stereolithographic (SLA) 3D-printed tablets. AAPS PharmSciTech. 2018:1–7.

  18. Ji F, Zhang C, Chen X, editors. Structure optimization of porous dental implant based on 3D printing. Materials science and engineering conference series; 2018, 324, 012060.

  19. Seng HL, Chia SMY, Kang L, Yap YL. Three-dimensional printing of carbamazepine sustained-release scaffold. J Pharm Sci. 2016;105(7):2155–63.

    Article  Google Scholar 

  20. Tagami T, Nagata N, Hayashi N, Ogawa E, Fukushige K, Sakai N, et al. Defined drug release from 3D-printed composite tablets consisting of drug-loaded polyvinylalcohol and a water-soluble or water-insoluble polymer filler. Int J Pharm. 2018;543:361–7.

    Article  CAS  PubMed  Google Scholar 

  21. Okwuosa TC, Stefaniak D, Arafat B, Isreb A, Wan KW, Alhnan MA. A lower temperature FDM 3D printing for the manufacture of patient-specific immediate release tablets. Pharm Res. 2016;33(11):2704–12.

    Article  CAS  PubMed  Google Scholar 

  22. Kollamaram G, Croker DM, Walker GM, Goyanes A, Basit AW, Gaisford S. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs. Int J Pharm. 2018;545(1–2):144–52.

    Article  CAS  PubMed  Google Scholar 

  23. Khaled SA, Burley JC, Alexander MR, Jing Y, Roberts CJ. 3D printing of tablets containing multiple drugs with defined release profiles. Int J Pharm. 2015;494(2):643–50.

    Article  CAS  PubMed  Google Scholar 

  24. Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. J Control Release. 2015;217:308–14.

    Article  CAS  PubMed  Google Scholar 

  25. Khaled SA, Alexander MR, Wildman RD, Wallace MJ, Sharpe S, Yoo J, et al. 3D extrusion printing of high drug loading immediate release paracetamol tablets. Int J Pharm. 2018;538(1–2):223–30.

    Article  CAS  PubMed  Google Scholar 

  26. Khirwadkar P, Dashora K. A review: fast dissolving drug delivery system: current developments in novel system design and technology. International Journal of Biomedical & Advance Research. 2012;3(2).

  27. Rattanakit P, Moulton SE, Santiago KS, Liawruangrath S, Wallace GG. Extrusion printed polymer structures: a facile and versatile approach to tailored drug delivery platforms. Int J Pharm. 2012;422(1):254–63.

    Article  CAS  PubMed  Google Scholar 

  28. Choi YM, Jun HJ, Dawson K, Rodriguez RL, Mi RR, Jun J, et al. Effects of the isoflavone puerarin and its glycosides on melanogenesis in B16 melanocytes. Eur Food Res Technol. 2010;231(1):75–83.

    Article  CAS  Google Scholar 

  29. Luo CF, Yuan M, Chen MS, Liu SM, Zhu L, Huang BY, et al. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration. Int J Pharm. 2011;410(1):138–44.

    Article  CAS  PubMed  Google Scholar 

  30. Zhang Y, Wang R, Wu J, Shen Q. Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery. Int J Pharm. 2012;427(2):337–44.

    Article  CAS  PubMed  Google Scholar 

  31. Shengmiao C, Chunshun Z, Xing T, Dawei C, Zhonggui H. Study on the bioavailability of puerarin from Pueraria lobata isoflavone self-microemulsifying drug-delivery systems and tablets in rabbits by liquid chromatography-mass spectrometry. Biomed Chromatogr. 2010;19(5):375–8.

    Google Scholar 

  32. Yan-Hong WU, Zi-Ren SU, Lai XP, Lin J. Pharmacokinetics and bioavailability of Yufeng Ningxin tablet in beagle dog. Chinese Traditional Patent Medicine. 2006;28(2):215–8.

    Google Scholar 

  33. Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. Journal of Controlled Release Official Journal of the Controlled Release Society. 2000;63(3):235–59.

    Article  CAS  PubMed  Google Scholar 

  34. Goyanes A, Buanz ABM, Hatton GB, Gaisford S, Basit AW. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. European Journal of Pharmaceutics & Biopharmaceutics Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E V 2015;89:157–162.

  35. Darade A, Pathak S, Sharma S, Patravale V. Atovaquone oral bioavailability enhancement using electrospraying technology. European Journal of Pharmaceutical Sciences Official Journal of the European Federation for Pharmaceutical Sciences. 2017;111:195.

    Article  PubMed  Google Scholar 

  36. Shah VP, Tsong Y, Sathe P, Liu J-P. In vitro dissolution profile comparison—statistics and analysis of the similarity factor, f2. Pharm Res. 1998;15(6):889–96.

    Article  CAS  PubMed  Google Scholar 

  37. Zhu LX, Zhi C, Ying G, Huang SW, Shi SL, Hui L, et al. Correlation of in vitro release between total flavonoids and different ingredients in sustained-release pellets of Ginkgo biloba extract by f_2 fit factor method. Chinese traditional & herbal drugs. 2015.

  38. Karalis V, Magklara E, Shah VP, Macheras P. From drug delivery systems to drug release, dissolution, IVIVC, BCS, BDDCS, bioequivalence and biowaivers. Pharm Res. 2010;27(9):2018–29.

    Article  CAS  PubMed  Google Scholar 

  39. Meka VS, Songa AS, Nali SR, Battu JR, Kolapalli VR. Design and in vitro evaluation of effervescent gastric floating drug delivery systems of propanolol HCl. Investig Clin. 2012;53(1):60–70.

    Google Scholar 

  40. Zhang X, Zhang Y, Han H, Yang J, Xu B, Wang B, et al. Formulation optimization of gastro-retention tablets of paeonol and efficacy in treatment of experimental gastric ulcer. Chem Pharm Bull. 2017;65(8):706–13.

    Article  CAS  Google Scholar 

  41. Arza RA, Gonugunta CS, Veerareddy PR. Formulation and evaluation of swellable and floating gastroretentive ciprofloxacin hydrochloride tablets. AAPS PharmSciTech. 2009;10(1):220–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Kumar N, Soni S, Singh T, Kumar A, Ahmad FJ, Bhatnagar A, et al. Development and optimization of gastro-retentive controlled-release tablet of calcium-disodium edentate and its in vivo gamma scintigraphic evaluation. AAPS PharmSciTech. 2015;16(6):1270–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Sharma BG, Khanna K, Kumar N, Nishad DK, Basu M, Bhatnagar A. Development and gamma scintigraphy evaluation of gastro retentive calcium ion-based oral formulation; an innovative approach for the management of gastro-oesophageal reflux disease (GERD). Drug Dev Ind Pharm. 2017;1.

  44. Khaled SA, Burley JC, Alexander MR, Roberts CJ. Desktop 3D printing of controlled release pharmaceutical bilayer tablets. Int J Pharm. 2014;461(1–2):105–11.

    Article  CAS  PubMed  Google Scholar 

  45. Samana H, Grandy DB, Mike R, Craig DQM. A study of phase separation in peptide-loaded HPMC films using T(zero)-modulated temperature DSC, atomic force microscopy, and scanning electron microscopy. J Pharm Sci. 2004;93(7).

  46. Reynhardt EC. An NMR, DSC and X-ray investigation of the disaccharides sucrose, maltose and lactose. Mol Phys. 1990;69(6):1083–97.

    Article  CAS  Google Scholar 

  47. Craig DQM, Barsnes M, Royall PG, Kett VL. An evaluation of the use of modulated temperature DSC as a means of assessing the relaxation behaviour of amorphous lactose. Pharm Res. 2000;17(6):696–700.

    Article  CAS  PubMed  Google Scholar 

  48. Lerk CF, Andreae AC, Boer AHD, Hoog PD, Kussendrager K, Leverink JV. Alterations of α-lactose during differential scanning calorimetry. J Pharm Sci. 1984;73(6):856–7.

    Article  CAS  PubMed  Google Scholar 

  49. Hussain S, Grandy DB, Reading M, Craig DQM. A study of phase separation in peptide-loaded HPMC films using T zero -modulated temperature DSC, atomic force microscopy, and scanning electron microscopy. J Pharm Sci. 2004;93(7):1672–81.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful for the instrumental support received from JingXin Pharmaceutical Co., Ltd. (Zhejiang, China).

Funding

This work was supported by the National Science and Technology Major Project, belonging to the “Research on the key technology of new drug delivery system and industrialization of new projects” line (no. 2014ZX09507001004), and by the Open fund of the Key Laboratory of the Ministry of Education for TCM Viscera-State Theory and Applications, Liaoning University of Traditional Chinese Medicine, belonging to the “Research of gastro-retentive and control-released preparation of ginkgolide” line (no. zyzx1608).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xinggang Yang.

Ethics declarations

All procedures involving human participants in this study conformed to the ethical standards of the institutional and/or national research committee and complied with the 1964 Helsinki declaration and its later amendments and with other comparable ethical standards.

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, P., Zhang, S., Sun, W. et al. Flexibility of 3D Extruded Printing for a Novel Controlled-Release Puerarin Gastric Floating Tablet: Design of Internal Structure. AAPS PharmSciTech 20, 236 (2019). https://doi.org/10.1208/s12249-019-1455-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/s12249-019-1455-3

KEY WORDS

Navigation